Li-Fraumeni Syndrome: Symptoms, Causes, Diagnosis and Treatment

Written by Medicover Team and Medically Reviewed by Dr Kovvuru Bhaskar Reddy , Oncologists

Causes
Find a Doctor
Diagnosis
Treatment
FAQs
Book an Appointment

1. Causes 2. Find a Doctor 3. Diagnosis 4. Treatment 5. FAQs

Li-Fraumeni Syndrome is a rare inherited cancer predisposition disorder caused by mutations in the TP53 gene. Individuals with this condition have a significantly increased risk of developing various cancers, including breast cancer, bone cancer, brain tumors, soft tissue sarcomas, and leukemia, often at a young age. Early diagnosis, genetic counseling, and regular cancer screening are important for detecting cancers early and improving long-term outcomes.

What are the Symptoms of Li-Fraumeni Syndrome?

Individuals with LFS are at a heightened risk of developing a wide range of cancers, often at a younger age compared to the general population. The spectrum of cancers associated with LFS includes:

Common Cancer Types

Sarcomas: These cancers affect the bones and soft tissues.
Breast Cancer: Particularly prevalent in women with LFS.
Brain Tumors: Including gliomas and medulloblastomas.
Adrenocortical Carcinomas: Affecting the adrenal glands.
Leukemia: Particularly acute lymphoblastic leukemia (ALL).

Early-Onset Cancer

One of the hallmark features of LFS is the early onset of cancer. Children and young adults with this syndrome often present with malignancies that are typically observed in older populations. Consequently, regular and comprehensive cancer screening is crucial for early detection and improved outcomes.

What are the Causes of Li-Fraumeni Syndrome?

The primary cause of Li-Fraumeni Syndrome is a germline mutation in the TP53 gene, located on chromosome 17p13.1. The TP53 gene encodes the p53 protein, which acts as a tumor suppressor by regulating the cell cycle and initiating apoptosis in cells with damaged DNA. When this gene is mutated, the p53 protein loses its ability to control cell division, leading to an increased risk of malignancies.

Genetic Inheritance

LFS follows an autosomal dominant inheritance pattern. This means that a single copy of the mutated gene, inherited from either parent, is sufficient to predispose an individual to cancer. Approximately 70% of families meeting the clinical criteria for LFS have detectable TP53 mutations, while the remaining 30% might have mutations in other genes or unknown genetic factors.

De Novo Mutations

In some cases, individuals with LFS do not inherit the TP53 mutation from their parents. These instances are attributed to de novo mutations, which occur spontaneously in the germ cells of one of the parents or in the fertilized egg during early embryonic development.

When to See a Doctor for Li-Fraumeni Syndrome?

A strong family history of cancer, multiple cancers in one individual, or cancer diagnosed at an unusually young age should be evaluated by a Genetic Specialist, Oncologist, or Medical Geneticist. Early identification allows for appropriate surveillance and preventive care.

You should see a doctor if you have:

A family history of multiple early-onset cancers
More than one primary cancer diagnosis
Relatives known to carry a TP53 mutation

Seek prompt medical evaluation if:

New cancer-related symptoms develop
A suspicious lump or mass is detected
Unexplained neurological or systemic symptoms occur

These findings may indicate a malignancy requiring immediate investigation.

No doctors found for Lifraumeni Syndrome in any location.

How is Li-Fraumeni Syndrome Diagnosed?

Diagnosing LFS involves a combination of clinical criteria and genetic testing. The following steps are typically undertaken:

Clinical Criteria

The classic LFS criteria, also known as the Li-Fraumeni criteria, include:

A proband with a sarcoma diagnosed before age 45.
A first-degree relative with any cancer diagnosed before age 45.
Another first- or second-degree relative with any cancer diagnosed before age 45 or a sarcoma at any age.

Genetic Testing

Genetic testing for TP53 mutations is the definitive method for diagnosing LFS. This involves extracting DNA from a blood sample and analyzing it for mutations in the TP53 gene. Positive results confirm the diagnosis, while negative results do not entirely rule out LFS due to the potential presence of mutations in other genes.

What are the Treatment for Li-Fraumeni Syndrome?

The treatment for cancers in individuals with LFS follows standard oncological protocols, but with heightened caution due to the increased risk of secondary cancers. The management strategies include:

Surgical Interventions

Surgical removal of tumors is often the first line of treatment. Given the high risk of recurrence, surgical margins are meticulously assessed to ensure complete excision of malignant tissue.

Chemotherapy and Radiation Therapy

Chemotherapy and radiation therapy are used with caution in LFS patients. The mutational status of the TP53 gene can influence the effectiveness of these treatments, and there is a higher risk of treatment-induced secondary cancers. Consequently, oncologists may opt for alternative therapeutic strategies or lower doses of radiation.

Targeted Therapies

With advancements in precision medicine, targeted therapies that specifically address the molecular abnormalities in cancer cells are becoming increasingly relevant for LFS patients. Drugs that inhibit specific pathways involved in tumor growth and survival can offer promising outcomes with fewer side effects.

Your health is everything - prioritize your well-being today.

Consult Lifraumeni Syndrome Doctors Today

What is the Recovery Process for Li-Fraumeni Syndrome?

Li-Fraumeni Syndrome requires lifelong monitoring because of the ongoing risk of developing cancer. Recovery focuses on early detection, prompt treatment of malignancies, and maintaining overall health through regular surveillance.

Comprehensive follow-up care can improve outcomes and quality of life for affected individuals.